NZ735025A - Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males - Google Patents

Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males

Info

Publication number
NZ735025A
NZ735025A NZ735025A NZ73502516A NZ735025A NZ 735025 A NZ735025 A NZ 735025A NZ 735025 A NZ735025 A NZ 735025A NZ 73502516 A NZ73502516 A NZ 73502516A NZ 735025 A NZ735025 A NZ 735025A
Authority
NZ
New Zealand
Prior art keywords
somatic
fenugreek extract
sexual
fenugreek
sexual conditions
Prior art date
Application number
NZ735025A
Inventor
Sunil Bhaskaran
Ramasamy Venkatesh
Jith Veeravalli
Original Assignee
Ge Nutrients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Nutrients Inc filed Critical Ge Nutrients Inc
Publication of NZ735025A publication Critical patent/NZ735025A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Physiology (AREA)

Abstract

The invention relates to methods of preventing further decline of testosterone sexual hormones, and/or improving testosterone sexual hormonal level in an otherwise healthy aging male human subject aged between 40-75, by administering an extract of fenugreek or fenugreek seeds in a daily dose of from about 300 mg to about 600 mg for at least 12 weeks.
NZ735025A 2015-02-19 2016-02-18 Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males NZ735025A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562118314P 2015-02-19 2015-02-19
PCT/US2016/018521 WO2016134174A1 (en) 2015-02-19 2016-02-18 Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males

Publications (1)

Publication Number Publication Date
NZ735025A true NZ735025A (en) 2023-05-26

Family

ID=56689713

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ735025A NZ735025A (en) 2015-02-19 2016-02-18 Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males

Country Status (14)

Country Link
US (1) US10576118B2 (en)
EP (1) EP3258949B1 (en)
JP (1) JP2018505908A (en)
KR (1) KR20170118787A (en)
CN (1) CN107427544A (en)
AU (1) AU2016219927B2 (en)
BR (1) BR112017017687A2 (en)
CA (1) CA2977059C (en)
MY (1) MY198811A (en)
NZ (1) NZ735025A (en)
PH (1) PH12017501504A1 (en)
SG (2) SG11201706717TA (en)
WO (1) WO2016134174A1 (en)
ZA (1) ZA201706283B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4121074A4 (en) * 2020-03-19 2023-11-15 Idunn Technologies Discovery of fifteen new anti-aging plant extracts and identification of cellular processes they affect as new caloric restriction mimetics
KR20230136422A (en) 2022-03-18 2023-09-26 농업회사법인 현대에프엔비 주식회사 Method for preparing elephant garlic extract

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2206157C (en) 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek
US20080199517A1 (en) * 2007-02-19 2008-08-21 Indus Biotech Private Ltd Composition and a process thereof
US8217165B2 (en) * 2008-06-17 2012-07-10 Pawan Kumar Goel Process for the extraction of furostanolic saponins from fenugreek seeds
CN101496828B (en) * 2009-02-27 2011-07-27 湖南今汉生物医药技术有限公司 Use of total saponin extract of fenugreek
EP2934559A4 (en) 2012-12-05 2016-07-20 Ge Nutrients Inc Use of fenugreek extract to enhance female libido
US10111895B2 (en) * 2013-03-15 2018-10-30 Suzanne J. Paxton-Pierson Androgen effectors
IN2013DE03119A (en) * 2013-10-21 2015-04-24 Tanvir Ali Dr Syed
KR101579845B1 (en) * 2014-06-30 2015-12-23 이경수 Composition that comprising fenugreek extract or compound including fenugreek extract for preventing and improving the andropause or male menopause symptom which involves lethargy, hypotrophy, muscle weakness, increasing visceral fat, tiredness and stress, by increasing testosterone level, endurance, muscle mass and decreasing visceral fat and improving blood lipid composition, number of sperm and activation of sperm

Also Published As

Publication number Publication date
EP3258949A1 (en) 2017-12-27
BR112017017687A2 (en) 2018-04-10
ZA201706283B (en) 2021-03-31
SG11201706717TA (en) 2017-09-28
CA2977059C (en) 2022-08-30
US10576118B2 (en) 2020-03-03
MY198811A (en) 2023-09-29
EP3258949A4 (en) 2018-07-25
CN107427544A (en) 2017-12-01
KR20170118787A (en) 2017-10-25
SG10202108859YA (en) 2021-09-29
CA2977059A1 (en) 2016-08-25
WO2016134174A1 (en) 2016-08-25
EP3258949B1 (en) 2024-05-22
US20160243179A1 (en) 2016-08-25
AU2016219927B2 (en) 2021-01-28
JP2018505908A (en) 2018-03-01
PH12017501504A1 (en) 2018-02-05
AU2016219927A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
MX2018003331A (en) Administration of deuterated cftr potentiators.
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
EA201691454A1 (en) COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING
GB201100043D0 (en) Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
MX2018003569A (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses.
MX346576B (en) Methods and compositions suitable for promoting healthy skin.
EP3808367A3 (en) Targeting aneurysm disease by modulating phagocytosis pathways
MX348708B (en) Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate.
MY187233A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
MX2016009231A (en) Administration of tasimelteon under fasted conditions.
ZA201808086B (en) Method of treating diseases
MX2019009586A (en) Compositions and methods for treating disease associated with permeability of intestinal epithelium.
MX2017011937A (en) Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
NZ735025A (en) Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males
MX2018009662A (en) Method and pharmaceutical composition for treatment of neurodegeneration.
MX2015012455A (en) Method for the treatment of fatty liver disease.
PH12019500137A1 (en) Vaginal composition comprising a combination of estrogen and vitamin d
PH12018500886A1 (en) Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders
IN2014DN09240A (en)
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
GB2530226A (en) Chewable tablet
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
MX2020001217A (en) Methods of treating symptoms of gastroparesis using velusetrag.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 FEB 2025 BY DENNEMEYER AND CO. SARL

Effective date: 20240205